The PI3 Kinase Signaling Pathway in Prostate Cancer

被引:0
|
作者
Elfiky, Aymen A. [1 ]
Jiang, Zhenyang [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
关键词
Androgen receptor; mammalian target of rapamycin; phosphatidylinositol; 3-kinase; prostate cancer; PTEN; ANDROGEN RECEPTOR FUNCTION; PTEN GENOMIC DELETION; 4-PHOSPHATASE TYPE-II; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; HORMONAL-THERAPY; CELL-POPULATIONS; FISH ANALYSIS; MTOR COMPLEX; GENE FUSIONS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite recent advances in our understanding of the biological basis of prostate cancer, the management of the disease, especially in the castration-resistant phase, remains a significant challenge. Deregulation of the phosphatidylinositol 3-kinase (PI3K) pathway is increasingly implicated in a number of malignancies, including prostate carcinogenesis. In this review, we detail the role of this pathway in the pathogenesis of prostate cancer and the therapeutic implications of targeting it.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [31] PI3 kinase inhibitors as fungicides
    Cherukupalli, Govardhan R.
    Bathini, Suryanarayana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [32] Prostate-specific inhibition of PI3 Kinase and protein synthesis as a therapy for advanced hormone cancer
    Baiz, Daniele
    Choi, Young A.
    Karpova, Yelena
    Yancey, Dana
    Hassan, Sazzad
    Sadelain, Michel
    Debinsk, Waldemar
    Kulik, George
    CANCER RESEARCH, 2012, 72
  • [33] Bz-423, a novel benzodiazpine, inhibits PI3 kinase signaling in ovarian cancer cells
    Garg, Gunjal
    Liu, Rebecca
    Boitano, Anthony
    Tan, Lijun
    Kwok, Roland
    Glick, Gary
    Opipari, Anthony
    CANCER RESEARCH, 2010, 70
  • [34] Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
    Ksionda, Olga
    Mues, Marsilius
    Wandler, Anica M.
    Donker, Lisa
    Tenhagen, Milou
    Jun, Jesse
    Ducker, Gregory S.
    Matlawska-Wasowska, Ksenia
    Shannon, Kevin
    Shokat, Kevan M.
    Roose, Jeroen P.
    PLOS ONE, 2018, 13 (05):
  • [35] PI3 kinase enhancer–Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis
    Rong Rong
    Jee-Yin Ahn
    Honglian Huang
    Eiichiro Nagata
    Daniel Kalman
    Judith A Kapp
    Jiancheng Tu
    Paul F Worley
    Solomon H Snyder
    Keqiang Ye
    Nature Neuroscience, 2003, 6 : 1153 - 1161
  • [36] Expression and Purification of PI3 Kinase α and Development of an ATP Depletion and an AlphaScreen PI3 Kinase Activity Assay
    Boldyreff, Brigitte
    Rasmussen, Tine L.
    Jensen, Hans H.
    Cloutier, Alexandre
    Beaudet, Lucille
    Roby, Philippe
    Issinger, Olaf-Georg
    JOURNAL OF BIOMOLECULAR SCREENING, 2008, 13 (10) : 1035 - 1040
  • [37] PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma
    Rajani Kanteti
    Jacob J. Riehm
    Immanuel Dhanasingh
    Frances E. Lennon
    Tamara Mirzapoiazova
    Bolot Mambetsariev
    Hedy L. Kindler
    Ravi Salgia
    Scientific Reports, 6
  • [38] PI3 KINASE PATHWAY ACTIVATION PROMOTES MALIGNANT PROGRESSION IN OLIGODENDROGLIAL TUMORS
    Tateishi, Kensuke
    Nakamura, Taishi
    Fink, Alexandria
    Lelic, Nina
    Matsushita, Yuko
    Koerner, Mara
    Murata, Hidetoshi
    Ichimura, Koichi
    Batchelor, Tracy
    Yamamoto, Tetsuya
    Chi, Andrew
    Iafrate, John
    Wakimoto, Hiroaki
    Cahill, Daniel
    NEURO-ONCOLOGY, 2018, 20 : 50 - 50
  • [39] PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma
    Kanteti, Rajani
    Riehm, Jacob J.
    Dhanasingh, Immanuel
    Lennon, Frances E.
    Mirzapoiazova, Tamara
    Mambetsariev, Bolot
    Kindler, Hedy L.
    Salgia, Ravi
    SCIENTIFIC REPORTS, 2016, 6
  • [40] PI3 kinase pathway activation to promote malignant progression in oligodendroglial tumor
    Tateishi, Kensuke
    Nakamura, Taishi
    Miyake, Shigeta
    Matsushita, Yuko
    Miyake, Yohei
    Yamanaka, Shoji
    Yamamoto, Tetsuya
    Ichimura, Kochi
    Wakimoto, Hiroaki
    Daniel, Cahill
    BRAIN PATHOLOGY, 2019, 29 : 68 - 68